Malaria vaccine development in Mali: a step towards transmission-blocking strategies.

Lancet Infect Dis

Clinical Epidemiology and Biostatistics Program, Faculty of Health Sciences, Universidad Científica del Sur, Lima, Peru; Grupo de Investigación Biomedicina, Facultad de Medicina, Fundación Universitaria Autónoma de las Américas-Institución Universitaria Visión de las Américas, Pereira 660003

Published: April 2024


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1473-3099(24)00064-1DOI Listing

Publication Analysis

Top Keywords

malaria vaccine
4
vaccine development
4
development mali
4
mali step
4
step transmission-blocking
4
transmission-blocking strategies
4
malaria
1
development
1
mali
1
step
1

Similar Publications

Introduction: Several sub-Saharan African countries are launching malaria vaccination programmes for children. We assessed how attitudes to malaria vaccination for children could be better understood by considering the individual dynamics of COVID-19 vaccine intention/uptake over the 2021-2023 campaigns, with a view to highlighting barriers likely to affect malaria vaccine uptake.

Methods: We conducted a six-wave telephone-based survey of 600 randomly selected Senegalese households.

View Article and Find Full Text PDF

Innate-like T cells (ILT), including γδ T cells (Vδ2s), Natural Killer T cells (NKTs) and Mucosal-associated Invariant T cells (MAITs), integrate innate and adaptive immunity, playing important roles in homeostatic conditions as well as during infection or inflammation. ILT are present on both sides of the fetal-maternal interface, but our knowledge of their phenotypical and functional features in neonates is limited. Using spectral flow cytometry we characterized cord blood ILT in neonates born to healthy women and women living with HIV.

View Article and Find Full Text PDF

Updated global distribution of Plasmodium vivax circumsporozoite protein variants and their correlation with vector susceptibility: A systematic review and meta-analysis.

Acta Trop

December 2024

Departamento de Microbiologia e Parasitologia, Centro de Investigação de Microrganismos, Instituto Biomédico, Universidade Federal Fluminense, Niterói, Rio de Janeiro 24020-141, Brazil; Programa de Pós-Graduação em Microbiologia e Parasitologia Aplicadas, Instituto Biomédico, Departamento de

The global distribution of Plasmodium vivax Circumsporozoite Protein variants (PvCSP), VK210, VK247, and P. vivax-like, plays a crucial role in malaria transmission and vaccine development. This systematic review and meta-analysis assessed the prevalence of these variants in humans and their association with Anopheles species worldwide.

View Article and Find Full Text PDF

Robust evaluation of vaccine effects based on estimation of vaccine efficacy curve.

Vaccine

September 2025

Centre for Quantitative Medicine, Duke-NUS Medical School, 20 College Road, 169856, Singapore; Signature Programme in Health Services & Systems Research, Duke-NUS Medical School, 8 College Road, 169857, Singapore; Tampere Center for Child, Adolescent and Maternal Health Research, Tampere University,

The Cox model and its extensions assuming proportional hazards is widely used to estimate vaccine efficacy (VE). However, when VE wanes over time, estimates can become sensitive to study duration and timing of vaccine delivery relative to disease seasonality, and may be biased due to sample attrition. Additionally, estimates of vaccine impact such as number of cases averted (NCA) are sensitive to background disease incidence and timing of vaccine delivery.

View Article and Find Full Text PDF